课题基金 / 基金详情

Estimating the contribution of BRCA2 to hereditary ovarian cancers in the French Canadian population of Quebec.

Estimating the contribution of BRCA2 to hereditary ovarian cancers in the French Canadian population of Quebec.
估计 BRCA2 对魁北克法裔加拿大人遗传性卵巢癌的影响。
批准号：
252426
负责人：
Dolman Lena
金额：
$1.27万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-02-01 至 2013-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=252426&lang=en
关键词：
Brca2 Cancer Genetics Cancer Susceptibility Founder Effects French Canadian Population Ovarian Cancer Recurrent Mutations

项目摘要

项目成果

Dolman Lena的其他基金

相似基金

相关文献

中文摘要
翻译
卵巢癌的存活率不到30%。在治疗最有效的早期阶段，没有筛查方法来发现疾病，而且很少有可用的有效治疗方案。大约10%的病例是由肠道菌群引起的
英文摘要
Ovarian cancer has a survival rate of less than 30%. There are no screening methods for the detection of early stage disease when treatment is most effective, and there are few available effective treatment options. About 10% of cases are due to the inher
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determining the efficacy, acceptability and safety of cold-coagulation treatment against cervical precancerious lesions in low-income countries
海外基金